Skip to main content
Log in

Use of rocuronium–sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy

  • Clinical Report
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

We compared the recovery time from neuromuscular blockade induced by rocuronium combined with sugammadex versus succinylcholine during electroconvulsive therapy (ECT). Anesthesia was induced using propofol, followed by succinylcholine (1 mg/kg) or rocuronium (0.6 mg/kg). Immediately after the seizure stopped, 16 mg/kg sugammadex was infused. Neuromuscular monitoring was performed and continued until recovery of the train-of-four ratio to 0.9. We compared the recovery time of T1 to 10 and 90% between groups. Patients were also assessed for clinical signs, such as time to first spontaneous breath from the administration of muscle relaxant and eye opening to verbal commands. Although recovery time of T1 to 10 and 90% in the rocuronium–sugammadex group was shorter than in the succinylcholine group, the difference was not statistically significant. Further, the seizure duration with succinylcholine (33 ± 8 s) was shorter than that with rocuronium–sugammadex (39 ± 4 s). In conclusion, this study demonstrates the potential benefit of use of rocuronium–sugammadex as an alternative to succinylcholine for muscle relaxation during ECT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kadoi Y, Saito S. Anesthetic considerations for electroconvulsive therapy—especially hemodynamic and respiratory management. Curr Psychiatr Rev. 2009;5:276–86.

    Article  Google Scholar 

  2. Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology. 2009;110:1020–5.

    Article  PubMed  CAS  Google Scholar 

  3. Lee C. Goodbye suxamethonium!. Anaesthesia. 2009;64:73–81.

    Article  PubMed  CAS  Google Scholar 

  4. Cheam EW, Critchley LA, Chui PT, Yap JC, Ha VW. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy. Can J Anesth. 1999;46:49–51.

    Article  PubMed  CAS  Google Scholar 

  5. Turkkal DC, Gokmen N, Yildiz A, Iyilikci L, Gokel E, Sagduyu K, Gunerli A. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. J Clin Anesth. 2008;20:589–93.

    Article  PubMed  Google Scholar 

  6. Kadar AG, Kramer BA, Barth MC, White PF. Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy. Anesth Analg. 2001;92:1171–2.

    Article  PubMed  CAS  Google Scholar 

  7. Janis K, Hess J, Fabian JA, Gillis M. Substitution of mivacurium for succinylcholine for ECT in elderly patients. Can J Anesth. 1995;42:612–3.

    Article  PubMed  CAS  Google Scholar 

  8. Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry. 1999;33:650–9.

    PubMed  CAS  Google Scholar 

  9. Nishiyama M, Togashi H. Effects of anesthetic agents on seizure duration and hemodynamics in electroconvulsive therapy (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2009;58:1266–9.

    Google Scholar 

  10. Setoyama K, Hirata T, Saeki H, Morimoto Y, Tsuruta S, Matsumoto M, Sakabe T. Anesthetic management for electroconvulsive therapy in the patients with a history of neuroleptic malignant syndrome (in Japanese with English abstract). Masui (Jpn J Anesthesiol). 2009;58:633–6.

    Google Scholar 

  11. Kelly D, Brull SJ. Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? Can J Anaesth. 1994;41:845–9.

    Article  PubMed  CAS  Google Scholar 

  12. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008;109:188–97.

    Article  PubMed  Google Scholar 

  13. Matsumoto N, Tomioka A, Sato T, Kawasaki M, Kadoi Y, Saito S. Relationship between cardiac output and onset of succinylcholine chloride action in electroconvulsive therapy patients. J ECT. 2009;25:246–9.

    Article  PubMed  Google Scholar 

  14. Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg. 2010;110:74–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuji Kadoi.

About this article

Cite this article

Hoshi, H., Kadoi, Y., Kamiyama, J. et al. Use of rocuronium–sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. J Anesth 25, 286–290 (2011). https://doi.org/10.1007/s00540-011-1095-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-011-1095-6

Keywords

Navigation